Protein,Protein_definition,Disease_category,Disease,method,nsnp,OR [95% CI],Pvalue,QTL_type
SFTPA1,Pulmonary surfactant-associated protein A1,Chapter X Diseases of the respiratory system,ILD,Inverse variance weighted,21,1.04 [1.02-1.06],9.73995315401028e-06,trans
SFTPA1,Pulmonary surfactant-associated protein A1,Chapter X Diseases of the respiratory system,J10_INTERSTITIUM,Inverse variance weighted,4,1.05 [1.03-1.08],2.06995701799198e-05,trans
SFTPA1,Pulmonary surfactant-associated protein A1,Chapter X Diseases of the respiratory system,IPF,Inverse variance weighted,20,1.03 [1.01-1.04],0.000562995497146283,trans
SFTPA1,Pulmonary surfactant-associated protein A1,Chapter IX Diseases of the circulatory system,I9_ATHSCLE,Inverse variance weighted,13,1.06 [1.01-1.11],0.0205125739085492,trans
SFTPA1,Pulmonary surfactant-associated protein A1,Chapter X Diseases of the respiratory system,J10_RESPIRATORY,Inverse variance weighted,15,1.13 [0.99-1.29],0.0721186947884018,trans
SFTPA1,Pulmonary surfactant-associated protein A1,Chapter V Mental and behavioural disorders,SMOKING_DEPEND,Wald ratio,1,1.05 [0.96-1.15],0.250061789160368,trans
SFTPA1,Pulmonary surfactant-associated protein A1,Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,Inverse variance weighted,11,0.99 [0.94-1.05],0.808587834715766,trans
